Breast Cancer

Zotatifin plus Faslodex and Verzenio was granted as a Fast Track Designation for the treatment of ER-positive, HER2-negative advanced or metastatic breast cancer.

The Truqap-Faslodex treatment combination offers “more options” for some patients with HR-positive, HER2-negative breast cancer, an expert told CURE®.

As Shannen Doherty revealed her cancer diagnoses and upcoming podcast and a woman with breast cancer completed her bucket list, here is what’s happening in the oncology space this week.

Peer- and self-evaluated techniques are being incorporated to improve the sexual health of women with breast cancer.

If metastatic breast cancer no longer responds to a given therapy, finding out what targetable mutations a patient has may guide the next steps for treatment, an expert said.

Since your diagnosis and treatments, how many life direction changes have you made?

The Food and Drug Administration approved six new cancer therapies in November 2023.

Being thankful for cancer seems like an odd concept to grasp.

Sara M. Tolaney, MD, MPH explains that treatment decisions for metastatic breast cancer are based on the current biopsy showing receptor status, but prior biopsies over the full course of disease are considered as well, particularly for HER2 targeted therapies which may work even if HER2 low expression occurred years earlier.

My experience with a cancer biopsy.

A recent study evaluated the low rate and racial disparities in utilization of palliative care.

While many parts of my cancer experience were extremely difficult, I tried to embrace it — and accept help when needed.

Losing someone to cancer never gets easier.

Truqap (capivasertib) with fulvestrant has been approved for the treatment of adults with HR-positive, HER2-negative locally advanced or metastatic breast cancer with one or more PIK3CA/AKT1/PTEN-alterations, the FDA announced.

Sara M. Tolaney, MD, MPH, states that all breast cancers should be tested for estrogen, progesterone, and HER2 receptors; HER2 testing involves an immunohistochemistry stain to quantify protein levels, with 3+ indicating HER2+ disease, 0 indicating HER2- disease, and 1-2+ levels needing additional FISH testing to clarify HER2 status.

Sara M. Tolaney, MD, MPH, introduces the role of HER2 as a breast cancer cell growth receptor and explains HER2-positive versus HER2-negative.

Where I grew up, cancer was not openly discussed.

Patients who had low levels of vitamin D before starting chemotherapy tended to have higher rates of chemotherapy-induced peripheral neuropathy, but more research is needed in this field.

After receiving a cancer diagnosis, it stays with you 24/7.

Up to a quarter of patients with breast cancer face financial burden due to the cost of supplements, complimentary therapy and alternative medicines which “may decrease adherence to prescribed medications,” researchers found.

An expert explained the different treatment options for patients with estrogen receptor-positive, HER2-negative breast cancer that has recently been diagnosed or has recurred.

Sometimes after a diagnosis of cancer, plans and attending events can become elusive due to symptoms and treatments.

A cancer community creates support and care throughout a cancer experience.

My world turned upside down in April 2013 on the anniversary of my mother in laws death from metastatic breast cancer.

Stephen Peck created a nonprofit that addressed the unique needs of men caring for someone with cancer.

Choosing to share your cancer story is a very personal choice.

From Suzanne Somers’ death from metastatic breast cancer and Julia Louis-Dreyfus discusses her outlook on life post-diagnosis, here is what’s happening in the oncology space this week.